Scientific publications

Clinical Pharmacology & Therapeutics, 2025

Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers

van Ruissen M., van Diemen M., Botros L. et al.

Discover Oncology, 2025

Causal association between inflammatory markers and malignant neoplasms of bone and articular cartilage using Mendelian randomization

Liu C., Yu C., Wang W. et al.

Scientific Reports, 2025

Comparison of three multiplex immunoassays for biomarker analysis in stratum corneum tape strips

Metwally N., de Boer F., Vreeken J. et al.

Scientific Reports, 2025

Sex- and strain-differential plasma proteomic signatures in C57BL/6 and BALB/c mice

Suh Y., Kim K.

Biomedicine & Pharmacotherapy, 2025

Apremilast attenuates hepatic steatosis and metabolic dysfunction in a murine model of MASLD: Implications for patients with Psoriatic disease

Ruiz-Ponce M., Rodriguez-Cuenca S., Martin-Salazar J. et al.

BMC Infectious Diseases, 2025

Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adults suspected of sepsis

Irani Shemirani M., Pernestig A., Björkman J. et al.

Investigative Ophthalmology & Visual Science, 2025

Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves’ Orbitopathy: A Proteomic Study

Hӧtte G., Kolijn P., de Bie M. et al.

Precision Clinical Medicine, 2025

Randomized Controlled Clinical Trial of Shenzhuo Formula in the Treatment of Macroalbuminuria in Diabetic Kidney Disease and Its Inflammation-Modulating Mechanisms

Anzhu W., Yishan H., Yu W. et al.

European Journal of Neurology, 2025

AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls

Bhandage A., Hoffmann S., Dusemund C. et al.

Cancer Letters, 2025

Bone marrow-based highly sensitive proteomics profiling reveals valuable biomarkers for pediatric B-cell acute lymphoblastic leukemia

Jiang Y., Liu F., Yang Y. et al.

Clinica Chimica Acta, 2025

Olink proteomics profiling platform reveals myocardial metabolism-associated protein biomarkers in heart failure with preserved ejection fraction (HFpEF)

Chen X., Huang Y., Liu L. et al.

PM&R, 2025

Genetically predicted KIR2DS4 mediate the association between gut microbe K10 and osteoporosis fractures: A mediation Mendelian randomization study

Wang Q., Kuang Q., Chen C. et al.

Arthritis Research & Therapy, 2025

Inflammation-related proteomics of extracellular vesicles as novel biomarkers for systemic lupus erythematosus revealed by proximity extension assay

Zhan S., Wang Z., Xu Y. et al.

Nutrition & Metabolism, 2025

Risk prediction of early-onset myocardial infarction using plasma proteomics, conventional risk factors, and polygenic risk score

Liu Z., Fang F., Qian Y. et al.

International Journal of Molecular Sciences, 2025

Low-Abundance Proteomics Reveal Pleiotrophin and Fibroblast Growth Factor-21 as Biomarkers of Metabolic Dysfunction-Associated Steatohepatitis

Milito M., Mihajlovic M., Mallia A. et al.

Immunology, 2025

Plasma Protein Fluctuation Trajectories Over 15 Years Before Rheumatoid Arthritis Onset

Sun C., Wang J., She W. et al.

Acta Paediatrica, 2025

Comparative Study Showed Significant Gene Expression Differences in Newborn Infants After Vaginal and Caesarean Deliveries

Carpén N., Helve O., Ericsson S. et al.

Nature Communications, 2025

Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma

Lei M., Leung C., Leung R. et al.

JACC, 2025

Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk

Bhatia H., McParland J., Rikhi R. et al.

Journal of Neurology, 2025

Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank

Buonocore J., Fratto E., Arcuri F. et al.